Thus, LILRB1 expression was reported in AML (127), certain T cell lymphomas (128–130), B-lineage lymphomas and leukemias (131–133), gastric cancer (134), ovarian cancer (126), and renal cell carcinoma (135). Here, LILRB1 is linked to renal cell carcinoma.